Nonakine

Drug Profile

Nonakine

Latest Information Update: 21 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gryphon Therapeutics
  • Class Viral fusion proteins
  • Mechanism of Action HIV fusion inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 14 Jul 2004 Phase-I/II clinical trials in HIV infections treatment in USA (Parenteral)
  • 29 Jul 2003 Data presented at the 2nd IAS Conference on HIV Pathogenesis and Treatment (IAS-2003) have been added to the HIV infections pharmacodynamics section
  • 28 Jul 2003 Preclinical trials in HIV infections treatment in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top